OPTX SYNTEC OPTICS HOLDINGS, INC.
Optical Instruments & Lenses · Nasdaq · SEC CIK 1866816 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-37.1%
TTM net income YoY75.3%
TTM EPS YoY75.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin22.1%
Operating margin0.2%
Net margin-2.4%
FCF margin-1.2%
EBITDA margin7.4%
Returns
ROE-3.6%
ROA-2.4%
ROIC (approx.)0.4%
Asset turnover0.99x
Leverage & solvency
Liabilities / assets18.7%
Debt / equity0.09x
Current ratio7.21x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-1.74x
Accruals ratio-6.5%
Payout ratio—
Capex / revenue5.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $28.08M | $28.45M |
| Cost of revenue | $21.55M | $22.75M |
| Gross profit | $6.53M | $5.70M |
| R&D expense | $600,000 | $1.00M |
| SG&A expense | $7.05M | $8.28M |
| Operating income | -$517,600 | -$2.58M |
| Pretax income | -$1.35M | -$2.99M |
| Income tax | $439,942 | -$514,832 |
| Net income | -$1.79M | -$2.48M |
| EBITDA | $2.10M | $189,319 |
| EPS (basic) | -0.05 | -0.07 |
| EPS (diluted) | -0.05 | -0.07 |
| Weighted avg. shares (diluted) | 36.92M | 36.69M |
| Balance sheet | ||
| Cash & equivalents | $358,867 | $598,787 |
| Receivables | $6.24M | $3.20M |
| Inventory | $7.88M | $6.95M |
| Current assets | $15.14M | $13.90M |
| PP&E, net | $9.17M | $11.67M |
| Total assets | $24.31M | $26.01M |
| Current liabilities | $11.23M | $10.57M |
| Short-term debt | $499,853 | $467,742 |
| Long-term debt | $2.13M | $2.61M |
| Total debt | $2.63M | $3.08M |
| Total liabilities | $14.77M | $14.97M |
| Shareholders' equity | $9.54M | $11.03M |
| Net debt | $2.27M | $2.48M |
| Shares outstanding | 36.92M | 36.69M |
| Cash flow statement | ||
| Operating cash flow | $672,635 | -$942,830 |
| Capital expenditure | $644,292 | $1.24M |
| Free cash flow | $28,343 | -$2.18M |
| Investing cash flow | -$644,292 | -$930,866 |
| Financing cash flow | -$268,263 | $314,238 |
| Depreciation & amortization | $2.61M | $2.77M |
| Stock-based compensation | $300,000 | $450,000 |
Free plan shows the latest 2 periods; Pro shows all 4 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.